Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Warren

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
The British Journal of Dermatology|July 28, 2016
Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigationE Theodorakopoulou, Z Z N Yiu, C Bundy, et al.
The British Journal of Dermatology|June 22, 2018
Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety databaseR B Warren, K Reich, R G Langley, et al.
The British Journal of Dermatology|May 13, 2021
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory diseaseA Al-Janabi, Z Littlewood, C E M Griffiths, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
The British Journal of Dermatology|April 4, 2017
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasisI Y K Iskandar, D M Ashcroft, R B Warren, et al.
The British Journal of Dermatology|November 20, 2008
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphismsR B Warren, R L Smith, E Campalani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort studyW Rungapiromnan, K J Mason, M Lunt, et al.
The British Journal of Dermatology|March 4, 2020
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Z Z N Yiu, K J Mason, P J Hampton, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burdenJ R Ingram, A V Marzano, E Prens, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
The British Journal of Dermatology|July 28, 2016
Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigationE Theodorakopoulou, Z Z N Yiu, C Bundy, et al.
The British Journal of Dermatology|June 22, 2018
Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety databaseR B Warren, K Reich, R G Langley, et al.
The British Journal of Dermatology|May 13, 2021
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory diseaseA Al-Janabi, Z Littlewood, C E M Griffiths, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
The British Journal of Dermatology|April 4, 2017
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasisI Y K Iskandar, D M Ashcroft, R B Warren, et al.
The British Journal of Dermatology|November 20, 2008
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphismsR B Warren, R L Smith, E Campalani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort studyW Rungapiromnan, K J Mason, M Lunt, et al.
The British Journal of Dermatology|March 4, 2020
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Z Z N Yiu, K J Mason, P J Hampton, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burdenJ R Ingram, A V Marzano, E Prens, et al.
Pageof 12